It’s not just the development of a COVID-19 vaccine that’s challenging – it’s the manufacturing, too. But how does the protection of Intellectual Property play into this purpose driven mission? Valneva CFO David Lawrence shares how they’ve been able to move quickly in ‘Vaccinating the Nation’ - the first in our series of Corporate Clarity Talks.
Disclaimer
The content of this webpage is for information only and is not intended to be construed as legal advice and should not be treated as a substitute for specific advice. Morton Fraser LLP accepts no responsibility for the content of any third party website to which this webpage refers. Morton Fraser LLP is authorised and regulated by the Financial Conduct Authority.
Jargon-busting Guide to Investment
For many start-up businesses, securing equity investment can be a confusing and daunting process.
Blog
/
30 November 2023
The Financial Services and Markets Act 2023: PAR revocations
Traditionally the UK has been ahead of the EU when it comes to financial products. Almost 10 years ago moves to set common standards amongst...
Blog
/
27 October 2023
The Banker's Duty of Confidentiality
The furore surrounding the closure of Nigel Farage's Coutts bank account escalated to the resignation of Dame Alison Rose as CEO of NatWest ...
Blog
/
26 October 2023